International Clinical Trial: Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy Participants

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824193) titled 'Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy Participants' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Epygenix

Condition: Drug Drug Interaction

Intervention: Drug: EPX-100 Drug: Itraconazole Drug: Phenytoin Drug: Omeprazole Drug: Midazolam

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: January 15, 2025

Target Sample Size: 54

Countries of Recruitment: United States

To know more, visit https://clinicalt...